P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial (vol 7, e240877, 2024)

被引：1
|
作者：
Min, P. K.
Kang, T. S.
Cho, Y. H.
机构：
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2024.13426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] 1-Year Safety of 3-Month Dual Antiplatelet Therapy Followed by Aspirin or P2Y12 Receptor Inhibitor Monotherapy Using a Bioabsorbable Polymer Sirolimus-Eluting Stent
    Kozuma, Ken
    Kinoshita, Yoshihisa
    Hioki, Hirofumi
    Nanasato, Mamoru
    Ito, Yoshiaki
    Yamaguchi, Junichi
    Shiode, Nobuo
    Hibi, Kiyoshi
    Tanabe, Kengo
    Ako, Junya
    Morino, Yoshihiro
    Hirohata, Atsushi
    Sonoda, Shinjo
    Nakagawa, Yoshihisa
    Ikari, Yuji
    CIRCULATION JOURNAL, 2021, 85 (01) : 19 - +
  • [42] Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents: The Dual Antiplatelet Therapy Randomized Clinical Trial (vol 313, pg 1113, 2015)
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (21): : 2185 - 2185
  • [43] Clinical Outcomes Of P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention In Patients With Acute Coronary Syndrome: A Meta-Analysis Of Randomized Controlled Trials
    Gupta, Soumya
    Thakkar, Aditya
    Aggarwal, Devika
    Bhatia, Kirtipal
    Choi, James
    Carter, Kristen
    Kaur, Arpanjeet
    Casso, Abel
    CIRCULATION, 2024, 150
  • [44] Abbreviated Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy versus 12 Months’ Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ashish Kumar
    Mariam Shariff
    Rajkumar Doshi
    Igor Pedreira Vaz
    American Journal of Cardiovascular Drugs, 2020, 20 : 355 - 361
  • [45] P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
    Guimaraes, Patricia O.
    Franken, Marcelo
    Tavares, Caio A. M.
    Silveira, Fabio S.
    Antunes, Murillo O.
    Bergo, Ricardo R.
    Joaquim, Rodrigo M.
    Hirai, Jessica C. S.
    Andrade, Pedro B.
    Pitta, Fabio G.
    Mariani, Jose, Jr.
    Nascimento, Bruno R.
    Silveira, Marcos S.
    Costa, Tiberio A. O.
    Dall'Orto, Frederico T. C.
    Serpa, Renato G.
    Sampaio, Fernanda B. A.
    Ohe, Louis N.
    Mangione, Fernanda M.
    Furtado, Remo H. M.
    Sarmento-Leite, Rogerio
    Monfardini, Frederico
    Assis, Silvia R. L.
    Nicolau, Jose C.
    Sposito, Andrei C.
    Lopes, Renato D.
    Onuma, Yoshinobu
    Valgimigli, Marco
    Angiolillo, Dominick J.
    Serruys, Patrick W.
    Berwanger, Otavio
    Bacal, Fernando
    Lemos, Pedro A.
    EUROINTERVENTION, 2023, 19 (04) : E323 - +
  • [46] The Efficacy and Safety of P2Y12 Inhibitors After a Short Course of Three Months or Less of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention and Drug-Eluting Stent Placement: A Meta-Analysis
    Elzanaty, Ahmed
    Nazir, Salik
    Awad, Mohammed
    Eltahawy, Ehab
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S16 - S16
  • [47] Letter by Sardar et al Regarding Article, "Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Randomized, Controlled Trial"
    Sardar, Partha
    Nairooz, Ramez
    Pekler, Gerald
    CIRCULATION, 2014, 130 (18) : E160 - E160
  • [48] P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis
    Ho, Ai-Chen
    Egolum, Ugochukwu
    Parker, Shanea
    Dimmel, Jordan
    Hawkins, Andrew
    Ling, Hua
    CLINICAL DRUG INVESTIGATION, 2020, 40 (09) : 799 - 808
  • [49] P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis
    Ai-Chen Ho
    Ugochukwu Egolum
    Shanea Parker
    Jordan Dimmel
    Andrew Hawkins
    Hua Ling
    Clinical Drug Investigation, 2020, 40 : 799 - 808
  • [50] Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized ClinicalTrial (vol 321, pg 2428, 2019)
    Hahn, J. Y.
    Song, Y. B.
    Oh, J. H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13): : 1316 - 1316
12345